The GALENICS PLATFORM of SPST offers opportunities for collaborative research toward innovative new drug discovery and development. The primary goal of the platform is to achieve greatest success through collaborative innovation, aimed at: tackling of new scientific challenges on biotarget discovery; molecular targeting and functional drug delivery; unveiling the molecular mechanism of key biotargets in drug discovery for life-threatening diseases.

The framework of our collaborative research covers Medicinaal chemistry, Molecular & structural biology, Cellular pharmacology, Pharmaceutics, Computational bioinformatics and Analytical chemistry.

Specific research areas of the Galenics Platform include: 1) design and development of tumor, immune system and CNS (BBB) targeted diagnostic or therapeutic drugs; 2) discovery and development of novel drug-delivery carriers and technologies; 3) structural and mechanistic studies of functional drug-delivery carriers and transporters.